As of March 26, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,575 confirmed measles cases in the United States for the year, spanning 32 jurisdictions with 16 outbreaks accounting for 94% of cases (1,483 total), nearly all among unvaccinated individuals (92%). This marks a sharp rise from 1,487 cases as of March 19, driven by sustained transmission in under-vaccinated communities amid declining MMR coverage (92.5% among kindergartners). Cases are tallied by rash onset date, so the March 31 total hinges on epidemiological week data; reporting lags of 1-2 weeks mean the next CDC update, expected early April, will clarify the final count and any late-March confirmations. No deaths reported, but 5% hospitalization rate underscores outbreak severity.
Resumen experimental generado por IA con datos de Polymarket · Actualizado¿Casos de sarampión en EE. UU. antes del 31 de marzo?
¿Casos de sarampión en EE. UU. antes del 31 de marzo?
$397,566 Vol.
31 mar 2026
1600
1%
1625
<1%
1650
<1%
1700
<1%
$397,566 Vol.
1600
$155,545 Vol.
1%
1625
$35,824 Vol.
<1%
1650
$64,269 Vol.
<1%
1700
$42,520 Vol.
<1%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,575 confirmed measles cases in the United States for the year, spanning 32 jurisdictions with 16 outbreaks accounting for 94% of cases (1,483 total), nearly all among unvaccinated individuals (92%). This marks a sharp rise from 1,487 cases as of March 19, driven by sustained transmission in under-vaccinated communities amid declining MMR coverage (92.5% among kindergartners). Cases are tallied by rash onset date, so the March 31 total hinges on epidemiological week data; reporting lags of 1-2 weeks mean the next CDC update, expected early April, will clarify the final count and any late-March confirmations. No deaths reported, but 5% hospitalization rate underscores outbreak severity.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Mar 23, 2026, 7:41 PM ET
Volumen
$397,566Fecha de finalización
31 mar 2026Mercado abierto
Mar 23, 2026, 7:41 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of March 26, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,575 confirmed measles cases in the United States for the year, spanning 32 jurisdictions with 16 outbreaks accounting for 94% of cases (1,483 total), nearly all among unvaccinated individuals (92%). This marks a sharp rise from 1,487 cases as of March 19, driven by sustained transmission in under-vaccinated communities amid declining MMR coverage (92.5% among kindergartners). Cases are tallied by rash onset date, so the March 31 total hinges on epidemiological week data; reporting lags of 1-2 weeks mean the next CDC update, expected early April, will clarify the final count and any late-March confirmations. No deaths reported, but 5% hospitalization rate underscores outbreak severity.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$397,566Fecha de finalización
31 mar 2026Mercado abierto
Mar 23, 2026, 7:41 PM ETResolver
0x65070BE91...As of March 26, 2026, the Centers for Disease Control and Prevention (CDC) reports 1,575 confirmed measles cases in the United States for the year, spanning 32 jurisdictions with 16 outbreaks accounting for 94% of cases (1,483 total), nearly all among unvaccinated individuals (92%). This marks a sharp rise from 1,487 cases as of March 19, driven by sustained transmission in under-vaccinated communities amid declining MMR coverage (92.5% among kindergartners). Cases are tallied by rash onset date, so the March 31 total hinges on epidemiological week data; reporting lags of 1-2 weeks mean the next CDC update, expected early April, will clarify the final count and any late-March confirmations. No deaths reported, but 5% hospitalization rate underscores outbreak severity.
Resumen experimental generado por IA con datos de Polymarket · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes